Approved Drugs for Ophthalmology
Acuvail (ketorolac tromethamine); Allergan;
For the treatment of pain and inflammation following cataract surgery., Approved July 2009
Bepreve (bepotastine besilate ophthalmic solution); Ista Pharmaceuticals;
For the treatment of itching associated with allergic conjunctivitis, Approved September 2009
Besivance (besifloxacin ophthalmic suspension); Bausch & Lomb;
For the treatment of bacterial conjunctivitis, Approved June 2009
Ozurdex (dexamethasone); Allergan;
For the treatment of macular edema following branch retinal vein occlusion or central retinal vein occlusion, Approved June 2009
Zirgan (ganciclovir ophthalmic gel); Sirion Therapeutics;
For the treatment of acute herpetic keratitis, Approved September 2009
Akten (lidocaine hydrochloride); Akorn;
For anesthesia during ophthalmologic procedures, Approved October 2008
Astepro (azelastine hydrochloride nasal spray); Meda Pharmaceuticals;
For the treatment of seasonal and perennial allergic rhinitis, Approved October 2008
Durezol (difluprednate); Sirion Therapeutics;
For the treatment of inflammation and pain associated with ocular surgery, Approved June 2008
AzaSite (azithromycin); InSite Vision;
For the treatment of bacterial conjunctivitis, Approved April 2007
Lucentis (ranibizumab); Genentech;
For the treatment of neovascular (wet) age related macular degeneration, Approved June 2006
Macugen (pegaptanib); Pfizer / Eyetech Pharmaceuticals;
For the treatment of wet age-related macular degeneration., Approved December 2004
Restasis (cyclosporine ophthalmic emulsion); Allergan;
For the treatment of low tear production., December 2002
Lumigan (bimatoprost ophthalmic solution); Allergan;
For the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension, Approved March 2001
Travatan (travoprost ophthalmic solution); Alcon;
For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, Approved March 2001
Valcyte (valganciclovir HCl); Roche;
For the treatment of cytomegalovirus retinitis in patients with AIDS, Approved March 2001
Betaxon; Alcon;
For lowering IOP in patients with chronic open-angle glaucoma or ocular hypertension, Approved February 2000
Quixin (levofloxacin); Santen;
For treatment of bacterial conjunctivitis, Approved August 2000
Rescula (unoprostone isopropyl ophthalmic solution) 0.15%; Ciba Vision;
For the treatment of open-angle glaucoma or ocular hypertension, Approved August 2000
Visudyne (verteporfin for injection); QLT;
For the treatment of wet age-related macular degeneration (wet AMD), Approved April 2000
Alamast; Santen;
pemirolast potassium ophthalmic solution, Approved September 1999
ZADITOR; Ciba Vision;
Treatment for the prevention of itching of the eye, Approved July 1999
Alrex; Bausch & Lomb, Pharmos;
Treatment for seasonal allergic conjunctivitis, Approved March 1998
Cosopt; Merck;
Treatment for glaucoma or ocular hypertension, Approved April 1998
Lotemax; Bausch & Lomb, Pharmos;
Treatment for post-operative eye inflammation, Approved March 1998
Salagen Tablets; MGI Pharma;
Treatment for Sjogren's Syndrome, Approved February 1998
Viroptic; King Pharmaceuticals;
Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998
Vitravene Injection; Isis Pharmaceuticals;
Treatment for CMV in AIDS patients, Approved August 1998
Acular (ketorolac tromethamine ophthalmic solution) 0.5%; Allergan;
Treatment for postoperative inflammation in patients who have undergone cataract extraction, Approved January 1997
Acular (ketorolac tromethamine ophthalmic solution) 0.5%; Allergan;
Treatment for post-surgical inflammation following cataract extraction, Approved November 1997
BSS Sterile Irrigating Solution; Alcon;
Treatment during ocular surgical procedures, Approved December 1997
AK-Con-A (naphazoline ophthalmic); Akorn;
Over-the-counter combination vasoconstrictor/antihistamine product for opthalmic use, Approved January 1996
Alphagan (brimonidine); Allergan;
Treatment for open-angle glaucoma and ocular hypertension, Approved September 1996
Ocuflox (ofloxacin opthalmic solution) 0.3%; Allergan;
Treatment for corneal ulcers, Approved May 1996
OcuHist; Pfizer;
Over-the-counter antihistamine eye drop, Approved January 1996
Vistide (cidofovir); Gilead;
Treatment for cytomegalovirus (CMV) retinitis, Approved June 1996
Vitrasert Implant; Chiron;
Drug delivery system for the treatment of cytomegalovirus, Approved March 1996
